The Global Flunixin Meglumine API Market was valued at USD 102.3 Million in 2023 and is projected to reach USD 145.8 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period (2024–2029). This steady growth is primarily fueled by the rising prevalence of livestock diseases, increasing demand for effective anti-inflammatory drugs in veterinary care, and the expansion of the global livestock industry, particularly in emerging economies.

As the veterinary pharmaceutical sector intensifies its focus on animal health and welfare, the production of high-quality Active Pharmaceutical Ingredients (APIs) becomes paramount. In this blog, we profile the Top 10 Companies in the Flunixin Meglumine API Industry—a group of specialized chemical and pharmaceutical manufacturers ensuring the supply of this critical non-steroidal anti-inflammatory drug (NSAID) for equine, bovine, and swine health.

Download FREE Sample Report:
Flunixin Meglumine API Market – View in Detailed Research Report

---

🔟 1. Rochem International Inc

Headquarters: Los Angeles, California, USA
Key Offering: High-Purity Flunixin Meglumine API

Rochem International Inc. is a prominent global supplier of pharmaceutical ingredients, including Flunixin Meglumine. The company specializes in sourcing and distributing APIs that meet stringent international quality standards, serving pharmaceutical manufacturers worldwide with a focus on reliability and supply chain efficiency.

Key Strengths:

• Extensive global distribution network

• Rigorous quality control and compliance with cGMP

• Strong relationships with veterinary drug manufacturers

---

9️⃣ 2. Ashland

Headquarters: Wilmington, Delaware, USA
Key Offering: Pharmaceutical-grade Flunixin Meglumine

Ashland is a leading global specialty chemicals company with a significant presence in the pharmaceutical sector. Its health and wellness segment provides high-purity ingredients, including Flunixin Meglumine API, supported by advanced R&D capabilities and a commitment to sustainability.

Key Strengths:

• Advanced solvent technology for API purification

• Global regulatory expertise

• Integrated supply chain from raw materials to finished APIs

---

8️⃣ 3. Excella GmbH

Headquarters: Frankfurt, Germany
Key Offering: cGMP-compliant Flunixin Meglumine

Excella GmbH, a part of the SEQENS group, is a respected European Contract Development and Manufacturing Organization (CDMO) specializing in highly potent APIs and complex molecules. The company offers Flunixin Meglumine produced under strict quality control systems.

Key Strengths:

• Expertise in complex organic synthesis

• Strong focus on European market compliance (EDQM)

• Custom manufacturing and development services

---

7️⃣ 4. Cayman Chemical

Headquarters: Ann Arbor, Michigan, USA
Key Offering: Research-grade Flunixin Meglumine

Cayman Chemical is a leading supplier of biochemicals for research and development, including high-purity Flunixin Meglumine used in preclinical studies and analytical testing. The company serves pharmaceutical companies and research institutions globally.

Key Strengths:

• High-purity standards for research applications

• Extensive catalog of biochemical tools

• Support for drug discovery and development

Download FREE Sample Report:
Flunixin Meglumine API Market – View in Detailed Research Report

---

6️⃣ 5. NGL Fine-Chem Ltd

Headquarters: Mumbai, India
Key Offering: Flunixin Meglumine API for veterinary formulations

NGL Fine-Chem Ltd is an Indian pharmaceutical company with a strong focus on veterinary APIs and formulations. The company manufactures Flunixin Meglumine and has a significant market presence in Asia and other emerging regions, leveraging cost-effective production capabilities.

Key Strengths:

• Cost-competitive manufacturing in India

• Vertically integrated production facilities

• Growing export market for veterinary pharmaceuticals

---

5️⃣ 6. Zhejiang Hisoar Pharmaceutical

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Flunixin Meglumine API (Solid and Liquid forms)

Zhejiang Hisoar Pharmaceutical is a major Chinese API manufacturer with a diverse portfolio that includes Flunixin Meglumine. The company exports its products globally and is known for its large-scale production capacity and competitive pricing.

Key Strengths:

• Large-scale manufacturing capacity

• Strong R&D focus on process optimization

• Established presence in international API markets

---

4️⃣ 7. Shandong Lukang Pharmaceutical Co., Ltd.

Headquarters: Jining, Shandong, China
Key Offering: Pharmaceutical-grade Flunixin Meglumine

Shandong Lukang Pharmaceutical is a comprehensive pharmaceutical enterprise in China with a robust API division. The company produces a wide range of APIs, including Flunixin Meglumine, and supplies both domestic and international markets.

Key Strengths:

• Integrated pharmaceutical company with full supply chain

• Compliance with multiple international pharmacopoeias

• Strategic location in a major Chinese pharmaceutical hub

---

3️⃣ 8. Hubei Longxiang Pharmaceutical Technology Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: High-quality Flunixin Meglumine API

Hubei Longxiang Pharmaceutical Technology specializes in the research, development, and production of pharmaceutical intermediates and APIs. The company is an emerging player in the Flunixin Meglumine market with a focus on technological innovation.

Key Strengths:

• Focus on technological advancement in API synthesis

• Growing manufacturing capabilities

• Strategic partnerships with formulation companies

---

2️⃣ 9. Shanghai Maclean Biochemical Technology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Flunixin Meglumine for veterinary use

Shanghai Maclean Biochemical Technology is a specialized supplier of biochemicals and pharmaceutical raw materials. The company provides Flunixin Meglumine API to veterinary pharmaceutical manufacturers, emphasizing quality and consistency.

Key Strengths:

• Specialization in biochemical and pharmaceutical raw materials

• Strong quality assurance protocols

• Responsive customer service and technical support

---

1️⃣ 10. Qilu Synva Pharmaceutical Co., Ltd.

Headquarters: Jinan, Shandong, China
Key Offering: Flunixin Meglumine API and formulations

Qilu Synva Pharmaceutical, part of the larger Qilu Pharmaceutical Group, is a significant manufacturer of APIs and finished dosage forms. The company produces Flunixin Meglumine and has a strong distribution network, particularly in the Asian market.

Key Strengths:

• Backing of a major pharmaceutical group

• Capabilities for both API and formulation manufacturing

• Established brand reputation in the pharmaceutical industry

Read Full Report:
Flunixin Meglumine API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Flunixin Meglumine API Is Driven by Animal Health Awareness

The Flunixin Meglumine API market is experiencing consistent growth, underpinned by the critical need for effective pain management and anti-inflammatory treatments in livestock. As the global population’s demand for animal protein rises, so does the emphasis on maintaining herd health, directly influencing the demand for essential veterinary pharmaceuticals.

📈 Key Trends Shaping the Market:

• Increasing adoption of intensive farming practices requiring herd health management

• Stringent regulatory standards for veterinary drug safety and efficacy

• Growth in the companion animal market, expanding beyond livestock applications

• R&D investments into improved drug delivery systems for veterinary NSAIDs

Read Full Report:
Flunixin Meglumine API Market – View in Detailed Research Report

The companies listed above are crucial to the veterinary pharmaceutical supply chain, ensuring the availability of a vital medication that supports animal welfare and productivity in the agricultural sector.